MP Group: Outlook on Microphysiological Systems (MPS) – The future of pre-clinical R&D

Outlook on ‘Microphysiological Systems (MPS) – The future of pre-clinical R&D’ that outlines the challenges with traditional drug testing, alternatives to the traditional methods, and the current and future perspective on MPS technologies. With a ~90% failure rate of drugs in clinical trials, the biopharma R&D continues to operate with substandard efficiency. The traditional drug testing methods (in-vitro and in-vivo) often fail to translate into clinical observations. Therefore, there is a high unmet need to develop in-vitro systems offering improved…

Continue Reading
Close Menu